Au, A. v., Milloth, E., Diel, I. J., Stefanovic, S., Hennigs, A., Wallwiener, M., . . . Domschke, C. (2016). Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: A randomized, open-label, non-inferiority Phase III trial. OncoTargets and therapy, 9, . https://doi.org/10.2147/OTT.S103130
Chicago-Zitierstil (17. Ausg.)Au, Alexandra von, et al. "Intravenous Pamidronate Versus Oral and Intravenous Clodronate in Bone Metastatic Breast Cancer: A Randomized, Open-label, Non-inferiority Phase III Trial." OncoTargets and Therapy 9 (2016). https://doi.org/10.2147/OTT.S103130.
MLA-Zitierstil (9. Ausg.)Au, Alexandra von, et al. "Intravenous Pamidronate Versus Oral and Intravenous Clodronate in Bone Metastatic Breast Cancer: A Randomized, Open-label, Non-inferiority Phase III Trial." OncoTargets and Therapy, vol. 9, 2016, https://doi.org/10.2147/OTT.S103130.